A study to learn if ritlecitinib is safe in adult participants with patchy hair loss due to alopecia areata
A study to learn if ritlecitinib is safe in adult participants with patchy hair loss due to alopecia areata. A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Safety of Ritlecitinib (PF-06651600) in Adult Participants With Alopecia Areata.
Category & Conditions: Immune System Diseases and Conditions
Medicine: ritlecitinib (PF-06651600)
ClinicalTrials.gov Identifier (NCT): NCT04517864
Protocol ID: B7981037
PrintDownloadOpen Plain Language Summary Result: Click here